In PLoS Medicine this week, researchers from the Breast Cancer Association Consortium and their collaborators report their classification of breast cancer subtypes for disease outcome over time based on five immunohistochemical markers.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.